Abstracts from 2014 through the most recent CROI can be viewed in this searchable database once they have been presented at the conference. Abstract Contents: The searchable database includes abstract text as submitted by the authors prior to CROI. Study data might be updated during the presentation at CROI. Please refer to the electronic poster or webcast for updates. Searching the Abstract Database: Enter the criteria below and click the “Search” button. After the search has been entered, the results will appear below the search form.

CROI conference materials (eg, the conference program, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Permission to replicate or reproduce these elements, in whole or in part, must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data (including figures within abstracts or electronic posters) are the property of the study authors. Permission to use data and figures cannot be given by IAS–USA unless it is for regulatory reasons. For more information, please email CROIabstracts@iasusa.org.

Search Results

1277 Results

942 – Immune Profile of Children With Post-COVID-19 Cardiac Contractility Alterations: A Prospective Study

Background Myocardial injuries have been observed after COVID-19 in previously healthy children, regardless of COVID-19 severity. Immune dysregulation may play a role in post-COVID cardiac alterations but remains unexplored in children. This study evaluated the immune response in children with or without asymptomatic cardiac contractility alterations after mild SARS-CoV-2 infection. Methods A prospective, observational study…

810 – Evaluation of Anal Cancer Screening in 18–34-Year-Old Men Who Have Sex With Men Living With HIV

Background New anal cancer screening guidelines recommend annual anal cytology (PAP) for men who have sex with men (MSM) living with HIV (LWH) aged ≥35 years. Historically our center had offered screening to even younger (>18 years) MSM LWH. There is a growing interest in expanding age-based cancer screening thresholds, including for anal cancer. We…

816 – Long-Term Outcomes in People With HIV Who Survive a Major Adverse Cardiovascular Event

Background Major adverse cardiovascular events (MACEs) are now a leading cause of morbidity and mortality in people with HIV (PWH). Data on the long-term outcomes of PWH who have survived a MACE are lacking. Our aim was to evaluate overall survival and its predictors in PWH who survived a MACE. Methods Retrospective cohort study on…

820 – No Increased Risk for Hypertension With CAB-LA Compared to TDF/FTC for PrEP: Results From HPTN 084

Background Several studies have suggested an increased risk for hypertension (HTN) associated with initiation of integrase strand transfer inhibitors (INSTIs) for HIV treatment that may be mediated by weight gain. We investigated whether CAB-LA was associated with an increased incidence of HTN in a post-hoc analysis of the HPTN 084 trial.  Methods HPTN 084 evaluated…

830 – BMI Is a Poor Surrogate for Excess Visceral Adiposity and Cardiovascular Risk in Persons With HIV

Background Recent studies demonstrate substantial weight gain among people with HIV (PWH) starting modern antiretroviral (ART) regimens, as well as a high prevalence of obesity among those on long-term treatment. As a result, routine body mass index (BMI) measurements have been proposed to assess cardiovascular (CV) and other comorbid illness risk. However, prior studies show…

844 – PLHIV Exhibit a COVID-19 Independent Increase of Cardiovascular Mortality in Brazil, 2019-2023

Background Cardiovascular disease (CVD) is a leading cause of morbidity and mortality among PLHIV. The COVID-19 pandemic exacerbated existing health disparities, particularly affecting vulnerable populations. This study aims to investigate the impact of the COVID-19 pandemic on death rates due to CVD in Brazil. Methods All data were sourced from Brazilian Mortality Information System (SIM)…

851 – People With HIV at High Cardiovascular Risk Were Undertreated With Statins

Background Recent studies highlight the importance of statin therapy in people with HIV (PWH), even with moderate overall cardiovascular (CV) risk. Our study aims to assess CV risk management in a cohort of PWH in Germany. Methods The HIV-HEART Ageing (HIVH) cohort is a prospective study assessing CV risk of PWH in the German Ruhr…

864 – Liraglutide for Obesity in HIV (LIROH): A Single-Arm, Open-Label Clinical Trial in South Africa

Background Obesity is a common complication of treated HIV, especially among Black Women. Yet, perceptions of optimal body weight among people living with HIV (PLWH) may influence interest in anti-obesity medical therapies. We conducted a pilot clinical trial to assess the acceptability, tolerability, and preliminary efficacy of liraglutide for obesity management in virologically suppressed PLWH…

889 – Multimorbidity and Quality of Life Among Older People Living With HIV in Urban Tanzania

Background Approximately one-third of Tanzanians living with HIV are aged ≥50. Aging persons living with HIV (PLWH) are at a higher risk of multi-morbidities compared to older persons without HIV. Multi-morbidities can have a significant negative impact on quality of life (QOL). This study assessed the distribution of geriatric and medical comorbidities and their association with…

891 – Re-Examining InSTI Effects on Weight Gain Among Treatment-Naive People With HIV in North America

Background Prior analyses highlighted the association between starting INSTI-based antiretroviral therapy (ART) and weight gain among treatment-naïve people with HIV (PWH) in the North American AIDS Cohort Collaboration on Research & Design (NA-ACCORD). However, it is unclear whether observed relative weight gain after INSTI initiation reflected weight-suppressive effects of older NNRTIs or confounding due to…